Effect of vehicles and esterification on the penetration and distribution of hypericin in the skin of hairless mice

Photodiagnosis and Photodynamic Therapy

Volumn 4, Issue 2, 2007, Pages 130-139

  Boiy, Annelies ^a   Roelandts, Rik ^b   Roskams, Tania ^a   de Witte, Peter A M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Fluorescence microscopy; Hypericin; Hypericin acetate ester; Skin penetration; Topical application

Indexed keywords

HYPERICIN; LANOLIN ALCOHOL; MACROGOL; PETROLATUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DERMIS; DRUG ACETYLATION; DRUG BINDING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG PENETRATION; ESTERIFICATION; FEMALE; FLUORESCENCE MICROSCOPY; HAIRLESS MOUSE; MOUSE; NONHUMAN; OINTMENT; PRIORITY JOURNAL; SEBACEOUS GLAND; STRATUM CORNEUM;

MUS;

EID: 34248161024     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2007.02.002     Document Type: Article

References (49)

1. Kopp B. Hypericum perforatum L., St. John's Wort, a medicinal plant in folk medicine. Wien Med Wochenschr 149 (1999) 190
2. Meruelo D., Lavie G., and Lavie D. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc Natl Acad Sci USA 85 (1988) 5230-5234
3. Avato P., Raffo F., Guglielmi G., Vitali C., and Rosato A. Extracts from St. John's Wort and their antimicrobial activity. Phytother Res 18 (2004) 230-232
4. Suzuki O., Katsumata Y., Oya M., Bladt S., and Wagner H. Inhibition of monoamine oxidase by hypericin. Plant Med 50 (1984) 272-274
5. Duran N., and Song P.S. Hypericin and its photodynamic action. Photochem Photobiol 43 (1986) 677-680
6. Lavie G., Mazur Y., Lavie D., and Meruelo D. The chemical and biological properties of hypericin - a compound with a broad spectrum of biological activities. Med Res Rev 15 (1995) 111-119
7. Chung P.S., Rhee C.K., Kim K.H., et al. Intratumoral hypericin and KTP laser therapy for transplanted squamous cell carcinoma. Laryngoscope 110 (2000) 1312-1316
8. Liu C.D., Kwan D., Saxton R.E., and McFadden D.W. Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. J Surg Res 93 (2000) 137-143
9. Kamuhabwa A.A.R., Roskams T., D'Hallewin M.A., Baert L., Van Poppel H., and de Witte P.A.M. Whole bladder wall photodynamic therapy of transitional cell carcinoma rat bladder tumors using intravesically administered hypericin. Int J Cancer 107 (2003) 460-467
10. Lavie G., Mandel M., Hazan S., et al. Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applications. Angiogenesis 8 (2005) 35-42
11. Morton C.A., Brown S.B., Collins S., et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 146 (2002) 552-567
12. Kurwa H.A., and Barlow R.J. The role of photodynamic therapy in dermatology. Clin Exp Dermatol 24 (1999) 143-148
13. Wolf P., Rieger E., and Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas?. J Am Acad Dermatol 28 (1993) 17-21
14. Peng Q., Warloe T., Moan J., et al. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 62 (1995) 906-913
15. Calzavara-Pinton P.G. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. J Photochem Photobiol B: Biol 29 (1995) 53-57
16. Chung P.S., Saxton R.E., Paiva M.B., et al. Hypericin uptake in rabbits and nude mice transplanted with human squamous cell carcinomas: study of a new sensitizer for laser phototherapy. Lanryngoscope 104 (1994) 1471-1476
17. Chen B., and de Witte P.A. Photodynamic therapy efficacy and tissue distribution of hypericin in a mouse P388 lymphoma tumor model. Cancer Lett 150 (2000) 111-117
18. Schempp C.M., Winghofer B., Langheinrich M., Schöpf E., and Simon J.C. Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St. John's Wort). Skin Pharmacol Appl Skin Physiol 12 (1999) 299-304
19. Kamuhabwa A.R., Roelandts R., and de Witte P.A. Skin photosensitization with topical hypericin in hairless mice. J Photochem Photobiol B: Biol 53 (1999) 110-114
20. Kamuhabwa A.R., Geboes K.R., and de Witte P.A. Investigation of the absorption of hypericin into the skin of hairless mice. J Pharm Pharmacol 52 (2000) 487-494
21. Falk H., Meyer J., and Oberreiter M. A convenient semisynthetic route to hypericin. Monatsh Chem 124 (1993) 339-341
22. Yamazaki T., Otha N., Yamazaki I., and Song P.S. Excited-state properties of hypericin: electronic spectra and fluorescence decay kinetics. J Phys Chem 97 (1993) 7870-7875
23. Huygens A., Kamuhabwa A.R., Van Cleynenbreugel B., Van Poppel H., Roskams T., and de Witte P.A. In vivo accumulation of different hypericin ion pairs in the urothelium of the rat bladder. BJU Int 95 (2005) 436-441
24. Barry B.W. Transdermal drug delivery. In: Aulton M.E. (Ed). Pharmaceutics: the science of dosage form design (2002), Harcourt Publishers Limited, London 500-524
25. Gloor M. How do dermatological vehicles influence the horny layer?. Skin Pharmacol Physiol 17 (2004) 267-273
26. Ogiso T., Iwaki M., and Paku T. Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J Pharm Sci 84 (1995) 482-488
27. Rostrup-Nielsen T., Pedersen L.S., and Villadsen J. Thermodynamics and kinetics of lipase catalysed hydrolysis of oleyl oleate. J Chem Technol Biotechnol 48 (1990) 467-482
28. Menon G.K., Grayson S., and Elias P.M. Cytochemical and biochemical localization of lipase and sphingomyelinase activity in mammalian epidermis. J Invest Dermatol 86 (1986) 591-597
29. Barry B.W. Mode of action of penetration enhancers in human skin. J Control Release 6 (1987) 85-97
30. Moser K., Kriwet K., Naik A., Kalia Y.N., and Guy R.H. Passive skin penetration enhancement and its quantification in vitro. Eur J Pharm Biopharm 52 (2001) 103-112
31. Santoyo S., Arellano A., Ygartua P., and Martin C. Penetration enhancer effects on the in vitro percutaneous absorption of piroxicam through rat skin. Int J Pharm 117 (1995) 219-224
32. Gwak H.S., and Chun I.K. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int J Pharm 236 (2002) 57-64
33. Agyralides G.G., Dallas P.P., and Rekkas D.M. Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques. Int J Pharm 281 (2004) 35-43
34. Mendelsohn R., Chen H.C., Rerek M.E., and Moore D.J. Infrared microspectroscopic imaging maps the spatial distribution of exogenous molecules in skin. J Biomed Opt 8 (2003) 185-190
35. Pugh W.J., Roberts M.S., and Hadgraft J. Epidermal permeability - penetrant structure relationships: 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. Int J Pharm 138 (1996) 149-165
36. du Plessis J., Pugh M.J., Judefeind A., and Hadgraft J. Physico-chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups. Eur J Pharm Sci 16 (2002) 107-112
37. Beisson F., Aoubala M., Marull S., et al. Use of the tape stripping technique for directly quantifying esterase activities in human stratum corneum. Anal Biochem 290 (2001) 179-185
38. Meyer W., and Neurand K. Hydrolytic enzymes in the sebaceous glands of the domestic cat. Histochem J 8 (1976) 639-646
39. Hikima T., Yamada K., Kimura T., Maibach H.I., and Tojo K. Comparison of skin distribution of hydrolytic activity for bioconversion of β-estradiol 17-acetate between man and several animals in vitro. Eur J Pharm Biopharm 54 (2002) 155-160
40. Motwani M.R., Rhein L.D., and Zatz J.L. Influence of vehicles on the phase transitions of model sebum. J Cosmet Sci 53 (2002) 35-42
41. Motwani M.R., Rhein L.D., and Zatz J.L. Deposition of salicylic acid into hamster sebaceous. J Cosmet Sci 55 (2004) 519-531
42. Hongcharu W., Taylor C.R., Chang Y., Aghassi D., Suthamjariya K., and Anderson R.R. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 115 (2000) 183-192
43. Pollock B., Turner D., Stringer M.R., et al. Topical aminolaevulinic acid - photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol 151 (2004) 616-622
44. Yova D., Hovhannisyan V., and Theodossiou T. Photochemical effects and hypericin photosensitized processes in collagen. J Biomed Opt 6 (2001) 52-57
45. Kielty C.M., Sherratt M.J., and Shuttleworth C.A. Elastic fibres. J Cell Sci 115 (2002) 2817-2828
46. el-Far M.A., and Pimstone N.R. The interaction of tumour-localizing porphyrins with collagen, elastin, gelatin, fibrin and fibrinogen. Cell Biochem Funct 3 (1985) 115-119
47. Grant W.E., Speight P.M., Hopper C., and Bown S.G. Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity. Int J Cancer 71 (1997) 937-942
48. Miyazawa S., Nishida K., Komiyama T., et al. Novel transdermal photodynamic therapy using ATX-S10.Na(II) induces apoptosis of synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice. Rheumatol Int 26 (2006) 717-725
49. Heckenkamp J., Aleksic M., Gawenda M., et al. Modulation of human adventitial fibroblast function by photodynamic therapy of collagen matrix. Eur J Vasc Endovasc Surg 28 (2004) 651-659